Malignant neoplasm of the cerebral meninges
Meaning of malignant neoplasm of the cerebral meninges: For the purposes of this Statement of Principles, malignant neoplasm of the cerebral meninges: (a) means a primary malignant neoplasm arising from the cells of the cerebral meninges; and (b) excludes soft tissue sarcoma, carcinoid tumour, non-Hodgkin's lymphoma, Hodgkin's lymphoma and melanoma. (3) While malignant neoplasm of the cerebral meninges attracts ICD-10-AM code C70.0 or C70.9, in applying this Statement of Principles the meaning of malignant neoplasm of the cerebral meninges is that given in subsection (2). (4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.
Reasonable Hypothesis (RH) — Statement of Principles No. 3 of 2018
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the cerebral meninges or death from malignant neoplasm of the cerebral meninges with the circumstances of a person's relevant service:
- (1)having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the brain at least five years before the clinical onset of malignant neoplasm of the cerebral meninges;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
- (2)being overweight or obese for at least five years within the 20 years before the clinical onset of malignant neoplasm of the cerebral meninges;
Note: being overweight or obese is defined in the Schedule 1 - Dictionary.
- (3)being in the second or third trimester of pregnancy, or within the 30 days postpartum, at the time of the clinical onset of malignant neoplasm of the cerebral meninges;
- (4)being treated with a drug as specified within the ten years before the clinical onset of malignant neoplasm of the cerebral meninges;
Note: being treated with a drug as specified is defined in the Schedule 1 - Dictionary.
- (5)using hormone replacement therapy for a continuous period of at least six months before the clinical onset of malignant neoplasm of the cerebral meninges, and where the use of hormone replacement therapy has ceased, the clinical onset of malignant neoplasm of the cerebral meninges has occurred within ten years of cessation;
Note: hormone replacement therapy is defined in the Schedule 1 - Dictionary.
- (6)being in the second or third trimester of pregnancy, or within the 30 days postpartum, at the time of the clinical worsening of malignant neoplasm of the cerebral meninges;
- (7)being treated with a drug as specified within the ten years before the clinical worsening of malignant neoplasm of the cerebral meninges;
Note: being treated with a drug as specified is defined in the Schedule 1 - Dictionary.
- (8)inability to obtain appropriate clinical management for malignant neoplasm of the cerebral meninges;
Aggravation-only factors: the factors in subsections 9(6) to 9(8) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.
Balance of Probabilities (BoP) — Statement of Principles No. 4 of 2018
7 factors
At least one of the following factors must exist before it can be said that, on the balance of probabilities, malignant neoplasm of the cerebral meninges or death from malignant neoplasm of the cerebral meninges is connected with the circumstances of a person's relevant service:
- (1)having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to the brain at least ten years before the clinical onset of malignant neoplasm of the cerebral meninges;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
- (2)being obese for at least ten years within the 20 years before the clinical onset of malignant neoplasm of the cerebral meninges;
Note: being obese is defined in the Schedule 1 - Dictionary.
- (3)being in the second or third trimester of pregnancy, or within the 30 days postpartum, at the time of the clinical onset of malignant neoplasm of the cerebral meninges;
- (4)being treated daily with cyproterone acetate at a dose rate of at least 15 milligrams per day for a continuous period of at least one year, within the ten years before the clinical onset of malignant neoplasm of the cerebral meninges;
- (5)being in the second or third trimester of pregnancy, or within the 30 days postpartum, at the time of the clinical worsening of malignant neoplasm of the cerebral meninges;
- (6)being treated daily with cyproterone acetate at a dose rate of at least 15 milligrams per day for a continuous period of at least one year, within the ten years before the clinical worsening of malignant neoplasm of the cerebral meninges;
- (7)inability to obtain appropriate clinical management for malignant neoplasm of the cerebral meninges;
Aggravation-only factors: the factors in subsections 9(5) to 9(7) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.
